This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Monsanto Will Profit Most From Bed Bug Epidemic, Poll Says

NEW YORK ( TheStreet) -- According to readers of TheStreet, the company most likely to benefit from the bed-bug epidemic is agricultural seed giant Monsanto (MON - Get Report) -- which also happens to be one the biggest names in the business of manufacturing pest control products.

While Monsanto garnered 21.7% of the votes in our poll on which stock is best poised to profit from the bed-bug outbreak, Sealy (ZZ) came in a close second, receiving 20.4% of the votes cast. Clorox (CLX - Get Report) came in third, with 15.3% of the votes.

E.I. du Pont de Nemours (DD - Get Report) picked up 14% of the votes, while Procter & Gamble (PG - Get Report) received 12.1%. Rollins (ROL - Get Report), Ecolab (ECL - Get Report) and Bayer AG (BAYRY) logged 7.6%, 5.1% and 3.8% respectively.

According to brand and communications company Hall & Partners, its WebWord tool -- which the company uses to monitor online "buzz" for clients and brands it's tracking -- shows that "fail" and "resistant" are among the words most strongly associated with searches on "bed bugs and cure." However, no brand is being singled as a failure. Likewise, no search results were showing up for "cure."

Hall & Partners believes these results indicate an important opportunity for many consumer goods companies. "While people are talking a lot about bed bugs lately, no one seems to know what to do with them," Hall & Partners director Brigette Lytle said.

"If a brand started talking about how they are a cure for bed bugs, they can have a stronghold in the market before anyone else gets out there with it."

According to reports, the bed-bug outbreak has reached record levels across the U.S., with Google's (GOOG) New York City office being among the latest to fall victim to the critters.

-- Written by Andrea Tse in New York.

>To contact the writer of this article, click here: Andrea Tse.

>To follow the writer on Twitter, go to Andrea Tse.

>To submit a news tip, send an email to:


Copyright 2010 Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
MON $90.04 -1.80%
PG $81.18 -0.51%
ROL $27.02 0.07%
ZZ $2.19 0.00%
DD $63.84 -0.65%


Chart of I:DJI
DOW 17,644.21 -7.05 -0.04%
S&P 500 2,053.26 +2.14 0.10%
NASDAQ 4,729.1960 +3.5570 0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs